























The	pathophysiology	of	 chronic	nonbacterial	osteomyelitis	 (CNO)	 remains	 incompletely	understood.	 Increased	NLRP3	 inflammasome	activation	and	 IL-1β	 release	 in	monocytes	 from	CNO	patients	was	 suggested	 to







single	 bones	 that	 can	 sometimes	be	 timely	 limited.	Most	 patients,	 however,	 experience	 chronic	 recurrent	 courses	with	more	 or	 less	 symmetric	 lesions	 at	multiple	 sites.	 Such	 courses	 are	 usually	 referred	 to	 as	 chronic	 recurrent
multifocal	osteomyelitis	(CRMO)	[1–3].	Particularly	cases	with	high	disease	activity,	and/or	delayed	diagnosis	and	treatment	initiation	are	prone	to	develop	additional	inflammatory	symptoms,	including	palmoplantar	pustulosis,	arthritis
or	bowel	inflammation.	Some	patients	experience	severe	sequelae,	such	as	vertebral	body	fractures.	Timely	diagnosis	and	initiation	of	effective	treatment	can	be	challenging	in	individual	cases	caused	by	the	absence	of	prospectively
tested	 disease	 biomarkers	 or	 diagnostic	 criteria	 [3,4].	 Thus,	CNO/CRMO	 remains	 a	 diagnosis	 of	 exclusion	 that	 requires	 the	 consideration	 of	 differential	 diagnoses,	 including	 infectious	 osteomyelitis,	malignancies	 and	 other	 rare
conditions	(such	as	the	metabolic	bone	disease	hypophosphatasia	and	other	autoinflammatory	conditions).	In	unclear	cases,	differential	diagnoses,	namely	bone	infection	or	malignancies,	require	to	be	excluded	through	bone	biopsies
[2,3,5].


























































































Increased	 expression	 of	 NLRP3	 inflammasome-associated	 genes	 in	 CNO/CRMO	 ‐‐–	 Based	 on	 findings	 from	 previous	 reports	 and	 the	 observations	 in	 Figure.	 1,	 monocytes	 are	 likely	 to	 be	 central	 players	 in	 the	 immune
pathogenesis	of	CNO/CRMO.	To	assess	 their	potential	 contribution	 to	bone	 inflammation,	we	monitored	mRNA	 (Figure.	3A)	and	protein	 (Figure.	3B,	 Supplement	 2A)	 expression	 of	 IL-1,	NLRP3,	 caspase-1,	 and	ASC	 (PYCARD	 gene).
Expression	of	 IL-1β	was	 increased	 in	monocytes	 from	CNO/CRMO	patients	 under	 resting	 conditions	 and	 in	 response	 to	 stimulation	with	TLR4	 ligand	LPS	on	 the	mRNA	 level	 and	 increased	 on	 the	 protein	 level	 after	 stimulation.
Furthermore,	secretion	of	mature	IL-1β	was	increased	in	both	resting	and	stimulated	(LPS)	monocytes	from	CNO/CRMO	patients	when	compared	to	controls	(Supplement	2B).	Expression	of	NRLP3	mRNA	and	protein	was	increased	in



























absolute	 and	 relative	numbers	 of	monocytes,	 neutrophils,	 T	 and	B	 lymphocytes.	 They	 furthermore,	 exhibited	 significant	 differences	 in	 immune	 cell	 numbers	 as	 compared	 to	 healthy	 controls	 (Table	1).	Next,	we	 for	 the	 first	 time
quantified	immune	cell	infiltrates	in	bone	biopsies	from	CNO/CRMO	patients	at	various	disease	stages	(“early”	vs.	“late”	stage)	and	compared	findings	to	bone	from	healthy	individuals	(osteotomy)	or	bacterial	osteomyelitis	(BOM).
Biopsies	 taken	at	any	stage	contained	monocytes,	neutrophils,	T	and	B	 lymphocytes,	and	plasma	cells.	However,	 “early”	 stage	 inflammation	was	characterized	by	 increased	absolute	numbers	of	monocytes,	 and	B	 lymphocytes	as
compared	to	later	stages.	Furthermore,	neutrophilic	granulozyte,	B	and	T	lymphocyte	proportions	were	elevated	in	“earlier”	stages	of	CNO	as	compared	to	chronic	stages.	Only	plasma	cells	appeared	to	increase	in	numbers	over	time
and	were	more	prevalent	in	“late	stage”-appearing	bone	lesions.	However,	since	plasma	cells	are	also	prevalent	in	bone	samples	from	BOM	patients,	the	sometimes-used	term	“plasma	cellular”	osteomyelitis	for	CNO/CRMO	appears
somewhat	misleading,	 since	 plasma	 cellular	 infiltrates	 are	 also	 present	 in	 BOM	 and	 therefore	 not	 specific	 to	 CNO/CRMO.	 Indeed,	 dense	 plasma	 cell	 infiltrates	 should	 trigger	 the	 consideration	 of	 differential	 diagnoses,	 such	 as
lymphoma.	Here	reported	observations	provide	evidence	for	a	coexistence	of	various	“disease	stages”	or	rather	mutual	involvement	of	innate	and	adaptive	immune	components	in	bone	inflammation	during	both	CNO/CRMO	and	BOM,
thus	underscoring	that	innate	and	adaptive	immune	responses	cannot	be	seen	as	individual	events.	Furthermore,	the	coexistence	of	innate	(monocytes	and	neutrophils)	and	adaptive	(lymphocyte)	immune	cell	infiltrates	in	CNO/CRMO





The	exact	molecular	mechanisms	that	contribute	to	 increased	gene	expression	and	activation,	however,	remained	unknown.	 In	the	present	study,	we	provide	evidence	for	 increased	mRNA	and	protein	expression	of	 inflammasome
associated	NLRP3,	ASC,	and	IL-1β.	Increased	abundance	of	inflammasome	components	NLRP3	and	ASC,	as	well	as	the	caspase-1	substrate	IL-1β	contribute	to	enhanced	inflammasome	assembly	and	subsequent	IL-1β	activation	and
























histopathology	 remains	difficult	using	currently	available	 tools.	Monocytes	are	prominent	 cellular	 components	of	 inflammatory	 infiltrates	 in	CNO/CRMO	at	all	 stages,	which	makes	 them	a	 likely	 contributor	 to	bone	 inflammation.
Monocytes	from	CRMO	patients	express	increased	levels	of	NLRP3	inflammasome	components	NLRP3	and	ASC,	as	well	as	IL-1β.	Altered	gene	expression	is	promoted	by	site-specific	DNA	demethylation	at	the	corresponding	genes
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• Immune	infiltrates	in	CNO	involve	cells	of	the	innate	and	adaptive	immune	system.
• Innate	immune	cells	may	drive	flares	in	analogy	to	Munro	abscesses	in	psoriasis.
• Monocytes	are	a	stable	and	almost	unchanged	element	of	all	CNO/CRMO	stages.
• Monocytes	from	CNO	patients	over-express	NLRP3,	ASC,	and	IL-1β
• Gene	expression	is	promoted	by	DNA	hypomethylation	at	NLRP3	and	PYCARD.
